A previous study on the autoantibody profile of glaucoma patients found a distinct loss of autoantibody targeting GFAP, which is a main type III intermediate filament protein of astrocytes [22] and considered a hallmark of astrocytes reactivity. The gene discussed is GFAP; the disease is glaucoma.